A wide swath of states and territories began legalizing medical cannabis, and decriminalizing its recreational use starting in 2012, in Washington and Colorado. Despite these developments, cannabis remains a "Schedule 1" drug under federal law alongside drugs like heroin and LSD. Polls suggest that a majority, and perhaps even two-thirds, of Americans support recreational cannabis legalization. This shift in public sentiment and progress in recent legislation have led to cannabis becoming more available to more consumer markets which has spurred growth and investor interest in the industry.
So what does this mean for investors?
The